🇺🇸 FDA
Patent

US 11725248

Evaluation of mantle cell lymphoma and methods related thereto

granted A61PA61P35/00A61P35/02

Quick answer

US patent 11725248 (Evaluation of mantle cell lymphoma and methods related thereto) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00, A61P35/02, A61P7/00